Review



d2 phaser x ray diffractometer  (Bruker Corporation)


Bioz Verified Symbol Bruker Corporation is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 99

    Structured Review

    Bruker Corporation d2 phaser x ray diffractometer
    Preparation and characteristics of Au-HA-functionalized SN38 NPs. (a) HA NPs are prepared by complexing SN38 with a human serum albumin (HSA)-based HA/PEI mixture. Simultaneously, Au NP-incorporated HA NPs (Au/HA NPs) are synthesized by integrating PEI-stabilized Au NPs into the HA/albumin complex. HA-functionalized SN38 NPs are prepared using a lyophilization–hydration method. (b) Transmission electron microscopy images of HA NPs and Au/HA NPs. Samples are negatively stained with 2 % uranyl acetate before imaging. Scale bar = 200 nm. (c) The average size and zeta potential of HA NPs and Au/HA NPs are analyzed using dynamic light scattering and aqueous electrophoresis. Each experimental group includes five samples ( n = 5). Data are expressed as the mean ± standard error of the mean. Statistical analyses are performed using the Mann–Whitney U test. (d) Full scan XPS spectrum of HA NPs and Au/HA NPs. <t>(e)</t> <t>X-ray</t> diffraction patterns of SN38, HA NP, and Au/HA NPs. (f) Storage stability of NPs as evaluated according to particle size (D) is determined by dissolving the re-lyophilized HA NPs and Au/HA NPs in 1 mL double-distilled water (ddH 2 O). Each experimental group include five samples ( n = 5). (g) Colloidal stability of NPs, as measured according to particle size (D), is assessed in Dulbecco's Modified Eagle Medium (Gibco) supplemented with 10 % ( v /v) fetal bovine serum to evaluate stability under physiologically relevant conditions. Each experimental group includes five samples (n = 5). (h) Representative and (i) quantitative cell surface CD44 expression posttreatment with SN38, HA NPs, and Au/HA NPs in A549, H226, and LLC cells as determined using flow cytometry. Each experimental group includes five samples (n = 5). Data are expressed as the mean ± standard error of the mean. Statistical significance is assessed using the one-way analysis of variance with Tukey's multiple comparisons test. * P < 0.05; ** P < 0.01; *** P < 0.001. Abbreviations: HA, hyaluronic acid; LLC, Lewis lung carcinoma; NP, nanoparticle; PEI, polyethyleneimine.
    D2 Phaser X Ray Diffractometer, supplied by Bruker Corporation, used in various techniques. Bioz Stars score: 99/100, based on 20048 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/d2+phaser+x+ray+diffractometer/D2+PHASER/pmc12808585-73-16-20
    Average 99 stars, based on 20048 article reviews
    d2 phaser x ray diffractometer - by Bioz Stars, 2026-09
    99/100 stars

    Images

    1) Product Images from "Gold-incorporated hyaluronic acid nanoparticles enhance ablative radiotherapy efficacy in lung cancer"

    Article Title: Gold-incorporated hyaluronic acid nanoparticles enhance ablative radiotherapy efficacy in lung cancer

    Journal: International Journal of Pharmaceutics: X

    doi: 10.1016/j.ijpx.2025.100480

    Preparation and characteristics of Au-HA-functionalized SN38 NPs. (a) HA NPs are prepared by complexing SN38 with a human serum albumin (HSA)-based HA/PEI mixture. Simultaneously, Au NP-incorporated HA NPs (Au/HA NPs) are synthesized by integrating PEI-stabilized Au NPs into the HA/albumin complex. HA-functionalized SN38 NPs are prepared using a lyophilization–hydration method. (b) Transmission electron microscopy images of HA NPs and Au/HA NPs. Samples are negatively stained with 2 % uranyl acetate before imaging. Scale bar = 200 nm. (c) The average size and zeta potential of HA NPs and Au/HA NPs are analyzed using dynamic light scattering and aqueous electrophoresis. Each experimental group includes five samples ( n = 5). Data are expressed as the mean ± standard error of the mean. Statistical analyses are performed using the Mann–Whitney U test. (d) Full scan XPS spectrum of HA NPs and Au/HA NPs. (e) X-ray diffraction patterns of SN38, HA NP, and Au/HA NPs. (f) Storage stability of NPs as evaluated according to particle size (D) is determined by dissolving the re-lyophilized HA NPs and Au/HA NPs in 1 mL double-distilled water (ddH 2 O). Each experimental group include five samples ( n = 5). (g) Colloidal stability of NPs, as measured according to particle size (D), is assessed in Dulbecco's Modified Eagle Medium (Gibco) supplemented with 10 % ( v /v) fetal bovine serum to evaluate stability under physiologically relevant conditions. Each experimental group includes five samples (n = 5). (h) Representative and (i) quantitative cell surface CD44 expression posttreatment with SN38, HA NPs, and Au/HA NPs in A549, H226, and LLC cells as determined using flow cytometry. Each experimental group includes five samples (n = 5). Data are expressed as the mean ± standard error of the mean. Statistical significance is assessed using the one-way analysis of variance with Tukey's multiple comparisons test. * P < 0.05; ** P < 0.01; *** P < 0.001. Abbreviations: HA, hyaluronic acid; LLC, Lewis lung carcinoma; NP, nanoparticle; PEI, polyethyleneimine.
    Figure Legend Snippet: Preparation and characteristics of Au-HA-functionalized SN38 NPs. (a) HA NPs are prepared by complexing SN38 with a human serum albumin (HSA)-based HA/PEI mixture. Simultaneously, Au NP-incorporated HA NPs (Au/HA NPs) are synthesized by integrating PEI-stabilized Au NPs into the HA/albumin complex. HA-functionalized SN38 NPs are prepared using a lyophilization–hydration method. (b) Transmission electron microscopy images of HA NPs and Au/HA NPs. Samples are negatively stained with 2 % uranyl acetate before imaging. Scale bar = 200 nm. (c) The average size and zeta potential of HA NPs and Au/HA NPs are analyzed using dynamic light scattering and aqueous electrophoresis. Each experimental group includes five samples ( n = 5). Data are expressed as the mean ± standard error of the mean. Statistical analyses are performed using the Mann–Whitney U test. (d) Full scan XPS spectrum of HA NPs and Au/HA NPs. (e) X-ray diffraction patterns of SN38, HA NP, and Au/HA NPs. (f) Storage stability of NPs as evaluated according to particle size (D) is determined by dissolving the re-lyophilized HA NPs and Au/HA NPs in 1 mL double-distilled water (ddH 2 O). Each experimental group include five samples ( n = 5). (g) Colloidal stability of NPs, as measured according to particle size (D), is assessed in Dulbecco's Modified Eagle Medium (Gibco) supplemented with 10 % ( v /v) fetal bovine serum to evaluate stability under physiologically relevant conditions. Each experimental group includes five samples (n = 5). (h) Representative and (i) quantitative cell surface CD44 expression posttreatment with SN38, HA NPs, and Au/HA NPs in A549, H226, and LLC cells as determined using flow cytometry. Each experimental group includes five samples (n = 5). Data are expressed as the mean ± standard error of the mean. Statistical significance is assessed using the one-way analysis of variance with Tukey's multiple comparisons test. * P < 0.05; ** P < 0.01; *** P < 0.001. Abbreviations: HA, hyaluronic acid; LLC, Lewis lung carcinoma; NP, nanoparticle; PEI, polyethyleneimine.

    Techniques Used: Synthesized, Lyophilization, Transmission Assay, Electron Microscopy, Staining, Imaging, Zeta Potential Analyzer, Electrophoresis, MANN-WHITNEY, Modification, Expressing, Flow Cytometry

    Related Articles

    X-ray Diffraction:

    Article Title: Development of UV-Resistant Chitosan/Starch Biofilms Reinforced with Chitosan Nanoparticles for Sustainable Packaging.
    Article Snippet: .. X-ray diffraction (XRD) measurements were carried out on a D2 PHASER X-ray diffractometer (Bruker Corporation, Billerica, USA) fitted with a CuKα radiation source (λ = 0.154 nm) to characterize the crystalline structure of the samples. ..

    Article Title: Gold-incorporated hyaluronic acid nanoparticles enhance ablative radiotherapy efficacy in lung cancer
    Article Snippet: .. Powder X-ray diffraction (XRD) patterns of SN38, HA NP, and Au/HA NP were recorded using a D2 PHASER X-ray diffractometer (Bruker Analytical X-Ray Solutions, Madison, WI, USA) equipped with a Cu Kα radiation source (λ = 1.5418 Å). .. The surface elemental composition of HA NP and Au/HA NPs was characterized by X-ray photoelectron spectroscopy (XPS) using a Hard X-ray Photoelectron Spectroscopy system (ULVAC-PHI Inc., Kanagawa, Japan) equipped with a monochromatic Al Kα source (1.4 keV, 150 W, 10 mA, 15 kV).

    Synthesized:

    Article Title: Visible-Light-Driven Photocatalytic Degradation of Dyes and Ciprofloxacin Using Coral-like β-Bi 2 O 3 .
    Article Snippet: .. The structure and phase purity of the synthesized materials were characterized using a Bruker D2 Phaser X-ray diffractometer (Bruker, Billerica, MA, USA) with a 1.54184 Å copper tube. ..

    Article Title: Visible-Light-Driven Photocatalytic Degradation of Dyes and Ciprofloxacin Using Coral-like β-Bi 2 O 3
    Article Snippet: .. The structure and phase purity of the synthesized materials were characterized using a Bruker D2 Phaser X-ray diffractometer (Bruker, Billerica, MA, USA) with a 1.54184 Å copper tube. ..

    other:

    Article Title: Optimized production and characterization of ulvan from Ulva Lactuca with in vitro biological activities
    Article Snippet: The crystallinity of Ulvan were detected using the Bruker D2 Phaser X-ray diffractometer, which is equipped with Cu Kα radiation (λ = 1.5412 Å) and operates at 30 mA and 40 kV over a 2θ range of 5° to 85°.



    Similar Products

    99
    Bruker Corporation d2 phaser x ray diffractometer
    Preparation and characteristics of Au-HA-functionalized SN38 NPs. (a) HA NPs are prepared by complexing SN38 with a human serum albumin (HSA)-based HA/PEI mixture. Simultaneously, Au NP-incorporated HA NPs (Au/HA NPs) are synthesized by integrating PEI-stabilized Au NPs into the HA/albumin complex. HA-functionalized SN38 NPs are prepared using a lyophilization–hydration method. (b) Transmission electron microscopy images of HA NPs and Au/HA NPs. Samples are negatively stained with 2 % uranyl acetate before imaging. Scale bar = 200 nm. (c) The average size and zeta potential of HA NPs and Au/HA NPs are analyzed using dynamic light scattering and aqueous electrophoresis. Each experimental group includes five samples ( n = 5). Data are expressed as the mean ± standard error of the mean. Statistical analyses are performed using the Mann–Whitney U test. (d) Full scan XPS spectrum of HA NPs and Au/HA NPs. <t>(e)</t> <t>X-ray</t> diffraction patterns of SN38, HA NP, and Au/HA NPs. (f) Storage stability of NPs as evaluated according to particle size (D) is determined by dissolving the re-lyophilized HA NPs and Au/HA NPs in 1 mL double-distilled water (ddH 2 O). Each experimental group include five samples ( n = 5). (g) Colloidal stability of NPs, as measured according to particle size (D), is assessed in Dulbecco's Modified Eagle Medium (Gibco) supplemented with 10 % ( v /v) fetal bovine serum to evaluate stability under physiologically relevant conditions. Each experimental group includes five samples (n = 5). (h) Representative and (i) quantitative cell surface CD44 expression posttreatment with SN38, HA NPs, and Au/HA NPs in A549, H226, and LLC cells as determined using flow cytometry. Each experimental group includes five samples (n = 5). Data are expressed as the mean ± standard error of the mean. Statistical significance is assessed using the one-way analysis of variance with Tukey's multiple comparisons test. * P < 0.05; ** P < 0.01; *** P < 0.001. Abbreviations: HA, hyaluronic acid; LLC, Lewis lung carcinoma; NP, nanoparticle; PEI, polyethyleneimine.
    D2 Phaser X Ray Diffractometer, supplied by Bruker Corporation, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/d2+phaser+x+ray+diffractometer/D2+PHASER/pmc12808585-73-16-20
    Average 99 stars, based on 1 article reviews
    d2 phaser x ray diffractometer - by Bioz Stars, 2026-09
    99/100 stars
      Buy from Supplier

    99
    Bruker Corporation x ray diffractometer
    Preparation and characteristics of Au-HA-functionalized SN38 NPs. (a) HA NPs are prepared by complexing SN38 with a human serum albumin (HSA)-based HA/PEI mixture. Simultaneously, Au NP-incorporated HA NPs (Au/HA NPs) are synthesized by integrating PEI-stabilized Au NPs into the HA/albumin complex. HA-functionalized SN38 NPs are prepared using a lyophilization–hydration method. (b) Transmission electron microscopy images of HA NPs and Au/HA NPs. Samples are negatively stained with 2 % uranyl acetate before imaging. Scale bar = 200 nm. (c) The average size and zeta potential of HA NPs and Au/HA NPs are analyzed using dynamic light scattering and aqueous electrophoresis. Each experimental group includes five samples ( n = 5). Data are expressed as the mean ± standard error of the mean. Statistical analyses are performed using the Mann–Whitney U test. (d) Full scan XPS spectrum of HA NPs and Au/HA NPs. <t>(e)</t> <t>X-ray</t> diffraction patterns of SN38, HA NP, and Au/HA NPs. (f) Storage stability of NPs as evaluated according to particle size (D) is determined by dissolving the re-lyophilized HA NPs and Au/HA NPs in 1 mL double-distilled water (ddH 2 O). Each experimental group include five samples ( n = 5). (g) Colloidal stability of NPs, as measured according to particle size (D), is assessed in Dulbecco's Modified Eagle Medium (Gibco) supplemented with 10 % ( v /v) fetal bovine serum to evaluate stability under physiologically relevant conditions. Each experimental group includes five samples (n = 5). (h) Representative and (i) quantitative cell surface CD44 expression posttreatment with SN38, HA NPs, and Au/HA NPs in A549, H226, and LLC cells as determined using flow cytometry. Each experimental group includes five samples (n = 5). Data are expressed as the mean ± standard error of the mean. Statistical significance is assessed using the one-way analysis of variance with Tukey's multiple comparisons test. * P < 0.05; ** P < 0.01; *** P < 0.001. Abbreviations: HA, hyaluronic acid; LLC, Lewis lung carcinoma; NP, nanoparticle; PEI, polyethyleneimine.
    X Ray Diffractometer, supplied by Bruker Corporation, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/d2+phaser+x+ray+diffractometer/D2+PHASER/us12594544-581-7-9
    Average 99 stars, based on 1 article reviews
    x ray diffractometer - by Bioz Stars, 2026-09
    99/100 stars
      Buy from Supplier

    99
    Bruker Corporation d2 phaser x ray powder diffractometer
    Preparation and characteristics of Au-HA-functionalized SN38 NPs. (a) HA NPs are prepared by complexing SN38 with a human serum albumin (HSA)-based HA/PEI mixture. Simultaneously, Au NP-incorporated HA NPs (Au/HA NPs) are synthesized by integrating PEI-stabilized Au NPs into the HA/albumin complex. HA-functionalized SN38 NPs are prepared using a lyophilization–hydration method. (b) Transmission electron microscopy images of HA NPs and Au/HA NPs. Samples are negatively stained with 2 % uranyl acetate before imaging. Scale bar = 200 nm. (c) The average size and zeta potential of HA NPs and Au/HA NPs are analyzed using dynamic light scattering and aqueous electrophoresis. Each experimental group includes five samples ( n = 5). Data are expressed as the mean ± standard error of the mean. Statistical analyses are performed using the Mann–Whitney U test. (d) Full scan XPS spectrum of HA NPs and Au/HA NPs. <t>(e)</t> <t>X-ray</t> diffraction patterns of SN38, HA NP, and Au/HA NPs. (f) Storage stability of NPs as evaluated according to particle size (D) is determined by dissolving the re-lyophilized HA NPs and Au/HA NPs in 1 mL double-distilled water (ddH 2 O). Each experimental group include five samples ( n = 5). (g) Colloidal stability of NPs, as measured according to particle size (D), is assessed in Dulbecco's Modified Eagle Medium (Gibco) supplemented with 10 % ( v /v) fetal bovine serum to evaluate stability under physiologically relevant conditions. Each experimental group includes five samples (n = 5). (h) Representative and (i) quantitative cell surface CD44 expression posttreatment with SN38, HA NPs, and Au/HA NPs in A549, H226, and LLC cells as determined using flow cytometry. Each experimental group includes five samples (n = 5). Data are expressed as the mean ± standard error of the mean. Statistical significance is assessed using the one-way analysis of variance with Tukey's multiple comparisons test. * P < 0.05; ** P < 0.01; *** P < 0.001. Abbreviations: HA, hyaluronic acid; LLC, Lewis lung carcinoma; NP, nanoparticle; PEI, polyethyleneimine.
    D2 Phaser X Ray Powder Diffractometer, supplied by Bruker Corporation, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/d2+phaser+x+ray+diffractometer/D2+PHASER/us12595254-89-76-75
    Average 99 stars, based on 1 article reviews
    d2 phaser x ray powder diffractometer - by Bioz Stars, 2026-09
    99/100 stars
      Buy from Supplier

    99
    Bruker Corporation powder x ray diffractometer
    Preparation and characteristics of Au-HA-functionalized SN38 NPs. (a) HA NPs are prepared by complexing SN38 with a human serum albumin (HSA)-based HA/PEI mixture. Simultaneously, Au NP-incorporated HA NPs (Au/HA NPs) are synthesized by integrating PEI-stabilized Au NPs into the HA/albumin complex. HA-functionalized SN38 NPs are prepared using a lyophilization–hydration method. (b) Transmission electron microscopy images of HA NPs and Au/HA NPs. Samples are negatively stained with 2 % uranyl acetate before imaging. Scale bar = 200 nm. (c) The average size and zeta potential of HA NPs and Au/HA NPs are analyzed using dynamic light scattering and aqueous electrophoresis. Each experimental group includes five samples ( n = 5). Data are expressed as the mean ± standard error of the mean. Statistical analyses are performed using the Mann–Whitney U test. (d) Full scan XPS spectrum of HA NPs and Au/HA NPs. <t>(e)</t> <t>X-ray</t> diffraction patterns of SN38, HA NP, and Au/HA NPs. (f) Storage stability of NPs as evaluated according to particle size (D) is determined by dissolving the re-lyophilized HA NPs and Au/HA NPs in 1 mL double-distilled water (ddH 2 O). Each experimental group include five samples ( n = 5). (g) Colloidal stability of NPs, as measured according to particle size (D), is assessed in Dulbecco's Modified Eagle Medium (Gibco) supplemented with 10 % ( v /v) fetal bovine serum to evaluate stability under physiologically relevant conditions. Each experimental group includes five samples (n = 5). (h) Representative and (i) quantitative cell surface CD44 expression posttreatment with SN38, HA NPs, and Au/HA NPs in A549, H226, and LLC cells as determined using flow cytometry. Each experimental group includes five samples (n = 5). Data are expressed as the mean ± standard error of the mean. Statistical significance is assessed using the one-way analysis of variance with Tukey's multiple comparisons test. * P < 0.05; ** P < 0.01; *** P < 0.001. Abbreviations: HA, hyaluronic acid; LLC, Lewis lung carcinoma; NP, nanoparticle; PEI, polyethyleneimine.
    Powder X Ray Diffractometer, supplied by Bruker Corporation, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/d2+phaser+x+ray+diffractometer/D2+PHASER/10__1016_slash_j__conbuildmat__2026__146007-95-13-18
    Average 99 stars, based on 1 article reviews
    powder x ray diffractometer - by Bioz Stars, 2026-09
    99/100 stars
      Buy from Supplier

    Image Search Results


    Preparation and characteristics of Au-HA-functionalized SN38 NPs. (a) HA NPs are prepared by complexing SN38 with a human serum albumin (HSA)-based HA/PEI mixture. Simultaneously, Au NP-incorporated HA NPs (Au/HA NPs) are synthesized by integrating PEI-stabilized Au NPs into the HA/albumin complex. HA-functionalized SN38 NPs are prepared using a lyophilization–hydration method. (b) Transmission electron microscopy images of HA NPs and Au/HA NPs. Samples are negatively stained with 2 % uranyl acetate before imaging. Scale bar = 200 nm. (c) The average size and zeta potential of HA NPs and Au/HA NPs are analyzed using dynamic light scattering and aqueous electrophoresis. Each experimental group includes five samples ( n = 5). Data are expressed as the mean ± standard error of the mean. Statistical analyses are performed using the Mann–Whitney U test. (d) Full scan XPS spectrum of HA NPs and Au/HA NPs. (e) X-ray diffraction patterns of SN38, HA NP, and Au/HA NPs. (f) Storage stability of NPs as evaluated according to particle size (D) is determined by dissolving the re-lyophilized HA NPs and Au/HA NPs in 1 mL double-distilled water (ddH 2 O). Each experimental group include five samples ( n = 5). (g) Colloidal stability of NPs, as measured according to particle size (D), is assessed in Dulbecco's Modified Eagle Medium (Gibco) supplemented with 10 % ( v /v) fetal bovine serum to evaluate stability under physiologically relevant conditions. Each experimental group includes five samples (n = 5). (h) Representative and (i) quantitative cell surface CD44 expression posttreatment with SN38, HA NPs, and Au/HA NPs in A549, H226, and LLC cells as determined using flow cytometry. Each experimental group includes five samples (n = 5). Data are expressed as the mean ± standard error of the mean. Statistical significance is assessed using the one-way analysis of variance with Tukey's multiple comparisons test. * P < 0.05; ** P < 0.01; *** P < 0.001. Abbreviations: HA, hyaluronic acid; LLC, Lewis lung carcinoma; NP, nanoparticle; PEI, polyethyleneimine.

    Journal: International Journal of Pharmaceutics: X

    Article Title: Gold-incorporated hyaluronic acid nanoparticles enhance ablative radiotherapy efficacy in lung cancer

    doi: 10.1016/j.ijpx.2025.100480

    Figure Lengend Snippet: Preparation and characteristics of Au-HA-functionalized SN38 NPs. (a) HA NPs are prepared by complexing SN38 with a human serum albumin (HSA)-based HA/PEI mixture. Simultaneously, Au NP-incorporated HA NPs (Au/HA NPs) are synthesized by integrating PEI-stabilized Au NPs into the HA/albumin complex. HA-functionalized SN38 NPs are prepared using a lyophilization–hydration method. (b) Transmission electron microscopy images of HA NPs and Au/HA NPs. Samples are negatively stained with 2 % uranyl acetate before imaging. Scale bar = 200 nm. (c) The average size and zeta potential of HA NPs and Au/HA NPs are analyzed using dynamic light scattering and aqueous electrophoresis. Each experimental group includes five samples ( n = 5). Data are expressed as the mean ± standard error of the mean. Statistical analyses are performed using the Mann–Whitney U test. (d) Full scan XPS spectrum of HA NPs and Au/HA NPs. (e) X-ray diffraction patterns of SN38, HA NP, and Au/HA NPs. (f) Storage stability of NPs as evaluated according to particle size (D) is determined by dissolving the re-lyophilized HA NPs and Au/HA NPs in 1 mL double-distilled water (ddH 2 O). Each experimental group include five samples ( n = 5). (g) Colloidal stability of NPs, as measured according to particle size (D), is assessed in Dulbecco's Modified Eagle Medium (Gibco) supplemented with 10 % ( v /v) fetal bovine serum to evaluate stability under physiologically relevant conditions. Each experimental group includes five samples (n = 5). (h) Representative and (i) quantitative cell surface CD44 expression posttreatment with SN38, HA NPs, and Au/HA NPs in A549, H226, and LLC cells as determined using flow cytometry. Each experimental group includes five samples (n = 5). Data are expressed as the mean ± standard error of the mean. Statistical significance is assessed using the one-way analysis of variance with Tukey's multiple comparisons test. * P < 0.05; ** P < 0.01; *** P < 0.001. Abbreviations: HA, hyaluronic acid; LLC, Lewis lung carcinoma; NP, nanoparticle; PEI, polyethyleneimine.

    Article Snippet: Powder X-ray diffraction (XRD) patterns of SN38, HA NP, and Au/HA NP were recorded using a D2 PHASER X-ray diffractometer (Bruker Analytical X-Ray Solutions, Madison, WI, USA) equipped with a Cu Kα radiation source (λ = 1.5418 Å).

    Techniques: Synthesized, Lyophilization, Transmission Assay, Electron Microscopy, Staining, Imaging, Zeta Potential Analyzer, Electrophoresis, MANN-WHITNEY, Modification, Expressing, Flow Cytometry